NICE Proposes Expanding Quick Gullet Sponge Tests for NHS Patients

People experiencing persistent and severe indigestion could soon be offered rapid “sponge in the gullet” screenings to check for oesophageal cancer under new draft guidelines recommended for the NHS in England.
The diagnostic procedure can be performed in general practice surgeries within minutes and serves as a less invasive alternative to hospital-based endoscopies, which utilize a small camera to examine internal tissue. While these sponge tests are already available in select locations, the updated guidance proposes making them accessible across England.

Persistent heartburn or acid reflux can be associated with Barrett’s oesophagus, a condition where cellular changes increase the long-term risk of cancer. Estimates suggest that between one and two adults out of every 100 live with Barrett’s oesophagus. Although most individuals with the condition do not develop cancer, high demand for NHS endoscopies currently prevents some patients from being monitored as frequently as recommended.
The National Institute for Health and Care Excellence (NICE) stated that expanding the sponge tests, which are already utilized in certain regions, could provide additional patients with peace of mind.

The procedure involves patients swallowing a small, dissolving capsule attached to a thread. Once the capsule reaches the stomach, it dissolves to release a tiny sponge. A doctor then gently pulls the sponge back out through the patient’s mouth via the thread, collecting cells from the lining of the oesophagus along the way for subsequent laboratory analysis.
Prof. Jonathan Benger, chief executive of NICE, noted that the sponge tests provide a rapid and less invasive method to detect concerning cellular changes, assisting in identifying patients who require further investigation and treatment.

Prof. Peter Johnson, national clinical director for cancer at NHS England, remarked that the health service continually seeks improved methods to evaluate symptoms. He noted that thousands of patients have already benefited from the efficient test through ongoing pilots, describing consideration for a nationwide rollout as fantastic.
Johnson added that providing an easier method to examine the lining of the oesophagus for individuals suffering from acid reflux can significantly benefit patients by reducing the demand for more complex endoscopies and enabling the NHS to allocate resources toward detecting cancers earlier.
Nevertheless, NICE emphasized that no diagnostic test—including traditional endoscopies—identifies every case. Consequently, individuals who receive a clear result from a sponge test must still undergo long-term monitoring. The tests are designed to assist in detecting both oesophageal cancer and Barrett’s oesophagus in patients presenting with reflux disease.
Final recommendations from NICE are scheduled to be released in the new year.
Reflux can produce heartburn, characterized by a burning sensation in the central chest, alongside an unpleasant sour taste in the mouth resulting from stomach acid. Prolonged exposure can damage the oesophageal lining. Contributing factors can include a weakened or lax sphincter located at the junction where the food pipe meets the stomach, allowing digestive juices to flow backward. Additional risk factors for reflux include being overweight, smoking, and consuming alcohol.